drugset / Trial / NCT00881270

Dermacyd Infantile - Acceptability.

NCT00881270

Phase 4 Completed 31 enrolled Sanofi
Non-randomizedSingle-groupOpen-labelSupportive care

Summary

Primary Objective: To prove the safety of the formulation in normal conditions of use.

Timeline

Start
2009-03
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactic Acid Other / unclassified

Indications

No indication recorded.